Adrian Newman-Tancredi
15Patents
6h-index
29Co-inventors
66Inventor score
Filing activity: Jul 5, 1995 → Jan 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5684020A | Piperazine, piperidine and 1,2,5,6-tetrahydropyridine | Chemistry; Metallurgy | 19 | Expired |
| US5919784A | Heterocyclic aminomethyl compounds | Chemistry; Metallurgy | 17 | Expired |
| US5958927A | Indanol compounds | Chemistry; Metallurgy | 10 | Expired |
| US5753662A | Piperazine compounds | Chemistry; Metallurgy | 10 | Expired |
| US6153625A | Indan-1-ol compounds | Human Necessities | 9 | Expired |
| US5663191A | Benzopyran compounds as 5HT.sub.2C receptor antagonists | Human Necessities | 7 | Expired |
| US5723484A | Benzopyran compounds as 5-HT.sub.2C receptor antagonists | Human Necessities | 5 | Expired |
| US6127396A | Imidazoline compounds | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6060487A | Indanol compounds | Chemistry; Metallurgy | 2 | Expired |
| US6172097A | Spiro imidazoline compounds | Human Necessities | 1 | Expired |
| US6107345A | Benzocyclobutane compounds | Chemistry; Metallurgy | 0 | Expired |
| US11974992B2 | Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy | Human Necessities | 0 | Active |
| US10562853B2 | Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors | Chemistry; Metallurgy | 0 | Active |
| US8455550B2 | Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products | Chemistry; Metallurgy | 0 | Active |
| US11191758B2 | Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of VMAT inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.